Author

D. Bojadzic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

O. Alcazar· 2 shared P. Buchwald· 2 shared J. Chen· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

O. Alcazar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Small-Molecule In Vitro Inhibitors of the Coronavirus Spike - ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2

D. Bojadzic, O. Alcazar, J. Chen, P. Buchwald

The paper identifies small-molecule inhibitors of the SARS-CoV-2 spike-ACE2 interaction, showing they block viral entry with low micromolar activity.

bioRxiv · Oct 22, 2020Pharmacology & Toxicology

Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike - ACE2 Protein-Protein Interaction - A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19

D. Bojadzic, O. Alcazar, P. Buchwald

This paper identifies methylene blue as an inhibitor of the SARS-CoV-2 spike-ACE2 interaction, suggesting it may contribute to its antiviral activity against COVID-19.

bioRxiv · Aug 29, 2020Pharmacology & Toxicology